Internal Server Error

About Pioneer Group

Pioneer Group is a venture capital firm founded in 2020. It is primarily based out of London, United Kingdom. As of Mar 2026, Pioneer Group is an active investor, having invested in 26 companies, with 1 new investment in the last 12 months. It primarily invests in Seed round in United Kingdom based startups. Its investments are spread across a wide range of sectors from Life Sciences to High Tech and Environment Tech. Most recently it participated in the $***** Seed round of MNS Overall, Pioneer Group portfolio has seen 2 IPOs and 3 acquisitions including key companies like NuVision, BiVictriX Therapeutics and Haemostatix. A lot of funds co-invest with Pioneer Group, with names like The University of Nottingham sharing a substantial percentage of its portfolio. Pioneer Group has team of 32 people including 12 partners.
Key Metrics
Portfolio Count
Portfolio Sectors
Portfolio Locations
Rounds of Entry
Seed & Series A
Portfolio Acquisitions
Portfolio Soonicorns
Deals in last 12 months

Pioneer Group's List of Top Investments

Pioneer Group has a portfolio of 26 companies. Their most notable investments are in Béa Fertility and NEOBE Therapeutics.Their portfolio spans across and United Kingdom. They have invested in Life Sciences, High Tech, Environment Tech and 12 other sectors, across stages such as Seed, Series A stages. Here is the list of top investments by Pioneer Group:
Kinomica provides a bioinformatics platform for the development of precision medicine. The company's platform uses proprietary bioinformatics and LC-MS/MS phospho-proteomics to analyze cellular signaling activities and biochemical network reprogramming. The applications include disease mechanisms understanding, drug target & biomarker identification, monitoring of drug molecular efficacy, identification of likely responders to therapy and more.

Key facts about Kinomica

  • Founded Year: 2017
  • Location: Macclesfield (United Kingdom)
  • Stage: Series A
  • Total Funding till date: $5.16M
  • Employee Count: 22 as on Jun 30, 2025
  • Investors: BGF, Pioneer Group and 15 Others
  • Latest Funding Round: Series A, Dec 14, 2020, $*****
  • Highlight: Editors' Pick
Developer of targeted intracellular delivery platform for biological molecules. The company focuses on enabling targeted, intracellular delivery of protein therapeutics. It creates a novel solution to the intracellular bioavailability problem. The company’s platform aims to unlock therapeutic opportunities within cells that are currently difficult to drug.

Key facts about NanoSyrinx

  • Founded Year: 2018
  • Location: Coventry (United Kingdom)
  • Valuation: $*****
  • Stage: Series A
  • Total Funding till date: $21.6M
  • Employee Count: 29 as on Apr 30, 2026
  • Investors: BGF, Lilly and 15 Others
  • Latest Funding Round: Series A, Sep 10, 2024, $*****
  • Highlight: Editors' Pick
Developer of microbiome-based therapeutics for multiple disease targets. The company is engaged in developing an integrated anaerobic system which comprises of a closed system collection and processing benchtop system that will allow therapies to be produced outside of cleanrooms and in anaerobic environments. It aims to offer microbiome therapy to patients suffering from Inflammatory Bowel Disease and other diseases related to the gut.

Key facts about Enterobiotix

Developer of an ophthalmic therapies for ocular surface disease. The company’s product Omnigen is a biological wound dressing that aids the regeneration and healing of the surface of the eye. It is a human amniotic membrane-derived dry preserved biological matrix intended for wound care. Also has an OmniLenz bandage contact lens that allows suture-free transplantation.

Key facts about NuVision

Provider of ultra-sound sensors for pipeline monitoring. It offers a range of probes which provides information regarding cracks and physical faults in the pipeline and can operate at a high temperature. It can also be used for NDT imaging, dental imaging, and medical imaging.

Key facts about Novosound

Pioneer Group's Investments by Stage

Pioneer Group has made 6 investments in Seed stage with an average round size of $1.6M and 2 investments in Series A stage with an average round size of $1.31M.
Here are Pioneer Group's investments by stage:
Stage of entry
No. of Investments
Seed
6
Series A
2
Breakdown of Pioneer Group's investments by stage of entrySeed (6)Series A (2)
Note: We have considered here, only first round of investments

Pioneer Group's Investments by Sector

Pioneer Group has a diverse portfolio, with companies operating in the Life Sciences, HealthTech, High Tech, Healthcare and Internet of Things - Industry Applications. Notably, it has invested in 21 Enterprise (B2B) companies, 19 Tech companies, 7 Tech hardware companies and at least 5 companies focusing on Software.
Here are Pioneer Group's investments by sector:
Sector
No. of Investments
Life Sciences
7
HealthTech
2
High Tech
2
Healthcare
1
Internet of Things - Industry Applications
1
Others
1
Breakdown of Pioneer Group's investments by sectorsLife Sciences (7)HealthTech (2)
Note: We have considered here, only first round of investments

Pioneer Group's Investments by Geography

Pioneer Group has made most investments in United Kingdom (8).

Pioneer Group's recent investments

Pioneer Group has made 2 investments in 2026 so far - MNS and NuVision.
Here are the most recent investments by Pioneer Group:
Date
Company
Location
Round Details
Round Amount
Co-Investors
Mar 03, 2026
United Kingdom
Seed
7970
Feb 05, 2026
United Kingdom
Series B
1523
Mar 13, 2025
United Kingdom
Seed
9368
Feb 28, 2024
United Kingdom
Seed
6545
Nov 22, 2023
United Kingdom
Series A
7016
-

IPOs and Publicly Listed companies in Pioneer Group's Portfolio

2 of Pioneer Group's portfolio companies have become public. BiVictriX Therapeutics got listed on the London Stock Exchange (LSE), in Aug 2021 at marketcap of undefined.
Here are Pioneer Group's portfolio companies that went public:
Company
IPO Date
First Invested on
First Round of Investment
Round Size
Aug 12, 2021
-
-
6582
-
Mar 08, 2023
Series A
1735

Acquired companies in Pioneer Group's Portfolio

3 companies from Pioneer Group's portfolio have been acquired. The most recent acquisition was Alderley Analytical in Oct 2024 by Synexa Life Sciences for $*****.
Here are Pioneer Group's portfolio companies that got acquired most recently:
Company
Acquisition Date
First Invested on
First Round of Investment
Round Size
Oct 07, 2024
-
-
6712
Sep 24, 2020
-
-
2995
May 04, 2016
-
-
4319

Team profile of Pioneer Group

Pioneer Group has a team of 32 members including 12 Partners and 5 Principals located in United Kingdom, Ireland and 1 more location. Pioneer Group's team does not sit on the board of any company as of now.
Here is a list of top team members in Pioneer Group:
Name
Designation
Location
Board Memberships
Contact Details
Partner
United Kingdom
-
Partner
United Kingdom
-
Partner
Nottingham
-
Partner
United Kingdom
-
Partner
London
-
Partner
London
-
Partner
Dublin
-

Co-investors of Pioneer Group

Over the past 4 years, 32 investors have co-invested in Pioneer Group's portfolio companies. This includes funds and angels.

  • Invested before Pioneer GroupMercia, Midlands Engine Investment Fund and 11 others have invested in rounds before Pioneer Group. There are 2 companies where Mercia has invested before Pioneer Group and 2 companies where Midlands Engine Investment Fund has invested before Pioneer Group.
  • Top Co-investors of Pioneer Group18 investors entered a company along with Pioneer Group. These include investors like The University of Nottingham (1 company).
  • Invested after Pioneer GroupMercia Ventures (1 company) is the only investor which has invested in Pioneer Group's portfolio after their investments.

Recent News related to Pioneer Group

View all news related to Pioneer Group

FAQs about Pioneer Group

Tracxn powers 1,000+ customers across 30+ countries
Accel PartnersPartechIN-Q-TEL - USFujitsuTenityStanford